🇺🇸 FDA
Pipeline program

Digital Engagement Application (GD App)

TAK-669-4017

Approved other completed

Quick answer

Digital Engagement Application (GD App) for Gaucher Disease is a Approved program (other) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Gaucher Disease
Phase
Approved
Modality
other
Status
completed

Clinical trials